17-alpha-estradiol

17-alpha-estradiol has been studied in 136 papers since 1975: 4 trials and 3 observational studies in people, 83 in animals, 30 in cells, 4 reviews; 10 in the past year. It has not reached trials in people. The newest paper, Nov 13, 2026: “Effect of 17α-Estradiol on Spatial Learning and Memory in APOE4 and 5xFAD Mice: Examination of Sex, Treatment,…”.

InterventionPreclinical

136 papers study it1 more mentions it176 findingsUpdated

PubChemChEBI

2 new papers in 30 daysSee all 100 papers on 17-alpha-estradiol

At a glance

17-alpha-estradiol extends lifespan and improves muscle function in male mice; mouse results recur across independent labs. Body-weight results differ, and a mouse study reports reproductive-tract tumors in females. NIH funds much of the work, and a paper declares ties to Optispan.

176 findings in 80 papers from 1976 to 2026, 7 of them since May 2026

The findings reach people, from one lab or study; independent labs found the same change in mice. 43 independent labs in 14 countries.

“17alpha estradiol increased skin prolyl hydroxylase activity, increased soluble collagen content in the skin and increased urinary hydroxyproline excretion.”
17 alpha estradiol: separation of estrogen effect on collagen from other clinical and biochemical effects in manResearch communications in chemical pathology and pharmacology1976

14 of its findings point the other way.

Mice: replicated by independent labs. Cells and humans: a single group. Worms or flies: nothing yet.
  • 43 independent labs in 14 countries
  • 14 findings against
  • Funders: National Institutes of Health and others
  • 1 of 164 findings with company ties
  • Human trial3
  • Animals72
  • Model organisms1
  • Cells18
  • In silico1

Studies in people

2 studies gave 17-alpha-estradiol to people and measured what changed.

What changedDesignPeopleSource

up: Improves safety

TrialGeneral populationAnnals of the New York Academy of Sciences, Jun 1, 2005

up: Increases skin collagen

no change: Has no effect on blood pressure

Trialthree to six weeks5 peoplePatient cohortsResearch communications in chemical pathology and pharmacology, Apr 1, 1976

What did mouse lifespan tests of 17-alpha-estradiol find?

NIA ITP

The NIA Interventions Testing Program ran 4 arms from 2009 to 2016; the change in median lifespan ran from 0% to +19%.

What did studies of 17-alpha-estradiol find?

123

Studies of 17-alpha-estradiol measured 123 outcomes; the most studied are lifespan (8 studies), oxidative stress and ROS signaling (4) and body mass (4).

Lifespan

upin mice8no changein mice1+12% to +19% median lifespan

8 studies
  1. 17-alpha-estradiol extends lifespan in mice.

    Reviewmales

  2. 17-alpha-estradiol extends lifespan in Ndufs4-/- mice.

    Animalsin Ndufs4-/- mice

  3. 17-alpha-estradiol extends lifespan in mice (Longevity extension reported in males but not females).

    ReviewLongevity extension reported in males but not femalesmales

  4. 17-alpha-estradiol extends lifespan in mice (genetically heterogeneous CByB6F1 x C3D2F1 mice) (+19% median lifespan).

    Animalsgenetically heterogeneous CByB6F1 x C3D2F1 mice14.4 ppmmales

  5. 17-alpha-estradiol extends lifespan in mice.

    Reviewmales

  6. 17-alpha-estradiol showed no clear effect on lifespan in mice (no survival effect).

    Revieweight monthsfemales

  7. 17-alpha-estradiol extends lifespan in mice (+19% median survival).

    Reviewlivereight monthsmales

  8. 17-alpha-estradiol extends lifespan in mice (threefold higher dose).

    Animalsthreefold higher dosethreefold higher than previously usedlifelongmales

  9. 17-alpha-estradiol extends lifespan in mice (genetically heterogeneous mice, males) (+12% median lifespan).

    Animalsgenetically heterogeneous mice, malesmales

Oxidative stress and ROS signaling

downin mice2downin cells1downin rats1

4 studies
  1. 17-alpha-estradiol decreases oxidative stress and ROS signaling in mice (APOE4 knock-in).

    AnimalsAPOE4 knock-inbrain20 weeksmales

  2. 17-alpha-estradiol inhibits oxidative stress and ROS signaling in OVX rats.

    Animalsin OVX rats

  3. 17-alpha-estradiol decreases oxidative stress and ROS signaling in mice (oxygen-induced retinopathy).

    Animalsoxygen-induced retinopathysubcutaneous injectionretinaPND 7 to 17

  4. 17-alpha-estradiol decreases oxidative stress and ROS signaling in vitro copper ion-induced LDL oxidation (1.3-, 1.7-, and 2.7-fold prolongation of lag-phase).

    Cellsin vitro copper ion-induced LDL oxidation0.2, 0.4, and 1 micromol/ln = 6

More on Oxidative stress and ROS signaling

Body mass

downin mice2downin marmosets1downin rats1

4 studies
  1. 17-alpha-estradiol decreases body mass in marmosets.

    Animals0.37-0.47 or 0.62-0.72 mg/kg/dayshort treatment durationmales

  2. 17-alpha-estradiol decreases body mass in rats fed a high-fat diet.

    Animalsin rats fed a high-fat dietfemales

  3. 17-alpha-estradiol decreases body mass in mice.

    Animalsmales

  4. 17-alpha-estradiol decreases body mass in mouse models of obesity.

    Animalsin mouse models of obesity

Cognitive function

no changein mice1upin mice1upin rats1

3 studies
  1. 17-alpha-estradiol showed no clear effect on cognitive function in APOE3 or APOE4 targeted-replacement female mice.

    Animalsin APOE3 or APOE4 targeted-replacement female micechowbrain14.4ppm6 monthsfemales

  2. 17-alpha-estradiol improves cognitive function in mice (APOE4 knock-in).

    AnimalsAPOE4 knock-in20 weeksmales

  3. 17-alpha-estradiol improves cognitive function in AF64A-treated rats with partial chronic cholinergic deficiency.

    Animalsin AF64A-treated rats with partial chronic cholinergic deficiencybrain

Glucose tolerance

upin mice3

3 studies
  1. 17-alpha-estradiol improves glucose tolerance in APOE4 targeted-replacement female mice.

    Animalsin APOE4 targeted-replacement female micechow14.4ppm6 monthsfemales

  2. 17-alpha-estradiol improves glucose tolerance in VCD-treated female mice.

    Animalsin VCD-treated female mice16 weeksfemales

  3. 17-alpha-estradiol improves glucose tolerance in mice.

    Animalsmales

Adiposity

downin mice3

3 studies
  1. 17-alpha-estradiol decreases adiposity in APOE4 targeted-replacement female mice.

    Animalsin APOE4 targeted-replacement female micechow14.4ppm6 monthsfemales

  2. 17-alpha-estradiol decreases adiposity in mice.

    Reviewmales

  3. 17-alpha-estradiol prevents adiposity in ovariectomized mice.

    Animalsin ovariectomized micedietarysix weeksfemales

Body weight

downin mice1no changein mice1downin rats1

3 studies
  1. 17-alpha-estradiol decreases body weight in mice (APOE4 knock-in).

    AnimalsAPOE4 knock-in20 weeksmales

  2. 17-alpha-estradiol showed no clear effect on body weight in mice during four-month dietary treatment (p = 0.75).

    Animalsduring four-month dietary treatmentdietaryfour months

  3. 17-alpha-estradiol decreases body weight in rats (ovariectomized rats).

    Animalsovariectomized ratsparaventricular nucleus

Inflammation

downin mice2downin mouse cells1

3 studies
  1. 17-alpha-estradiol protects against inflammation in mice.

    Animalshypothalamusmales

  2. 17-alpha-estradiol decreases inflammation in mouse cells (LPS-induced).

    CellsLPS-induced

  3. 17-alpha-estradiol decreases inflammation in mice (age-associated hypothalamic inflammation; sex-specific).

    Animalsage-associated hypothalamic inflammation; sex-specifichypothalamusmales

More on Inflammation

Cell proliferation

downin human cells2upin mouse cells1

3 studies
  1. 17-alpha-estradiol inhibits cell proliferation in human cells.

    CellsLNCaP and MDA Pca-2b cells

  2. 17-alpha-estradiol decreases cell proliferation in human cells (DHT-treated cultured LAPC-4 cells).

    CellsDHT-treated cultured LAPC-4 cells

  3. 17-alpha-estradiol increases cell proliferation in mouse cells (peaks at 1 pg/ml (157.13%) and 100 ng/ml (120.04%) (p<0.05)).

    Cells

Catecholamine secretion

downin animals1downin F. catus1no changein rats1downin rats1

2 studies
  1. 17-alpha-estradiol showed no clear effect on catecholamine secretion in rats (evoked by high K+ (56 mM)).

    Animalsevoked by high K+ (56 mM)adrenal gland1-100 uM20 minmales

  2. 17-alpha-estradiol inhibits catecholamine secretion in rats (evoked by ACh, DMPP, McN-A-343 and Bay-K-8644) (1-100 uM).

    Animalsevoked by ACh, DMPP, McN-A-343 and Bay-K-8644adrenal gland1-100 uM20 minmales

  3. 17-alpha-estradiol decreases catecholamine secretion (evoked by pulses of 120 mM K+ for 10 sec).

    Animalsevoked by pulses of 120 mM K+ for 10 secadrenal gland

  4. 17-alpha-estradiol decreases catecholamine secretion in F. catus (evoked by pulses of DMPP (1 microM for 30 sec)) (decreased by 50 and 80%).

    Animalsevoked by pulses of DMPP (1 microM for 30 sec)adrenal gland1 and 10 microM

Blood pressure

no changein humans1no changein rats1

2 studies
  1. 17-alpha-estradiol showed no clear effect on blood pressure in humans.

    Human trialthree to six weeksn = 5

  2. 17-alpha-estradiol showed no clear effect on blood pressure in rats (spontaneously hypertensive rats).

    Animalsspontaneously hypertensive ratspellet dissolved in cholesterol800 μg pellet2 weeksmales

Skin collagen

upin humans1upin rodents1

1 study
  1. 17-alpha-estradiol increases skin collagen in humans.

    Human trialthree to six weeksn = 5

  2. 17-alpha-estradiol improves skin collagen in rodents (D-penicillamine-induced skin collagen changes).

    ReviewD-penicillamine-induced skin collagen changes

More on Skin collagen

Safety

upin humans1

1 study
  1. 17-alpha-estradiol improves safety in humans.

    Human trialsodium sulfate conjugate

All 123

What acts on 17-alpha-estradiol?

1

Studies name ESR2 as acting on 17-alpha-estradiol.

ESR2

mediatesin mice1

1 study
  1. ESR2 mediates 17-alpha-estradiol in 17α-E2-treated male mice.

    Animalsin 17α-E2-treated male micelivermales

More on ESR2

Funding

3 grants since 2018

National Institute on Aging$1.9M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    17-alpha-estradiol extends lifespan in male mice across independent labs; a study in male mice reports reduced sarcopenia. Mouse body-weight results include decreases and no change; a study in female mice reports reproductive-tract tumors. NIH and NIA support much of this work; one paper declares Optispan ties, and one group reports the human results.

  2. Summary rewritten as its findings changed.

    As it read before

    A mouse preprint reports reduced adiposity, improved glucose tolerance and increased energy expenditure in APOE4 targeted-replacement females, but no cognitive effect in APOE3 or APOE4 females, after six months at 14.4 ppm in chow. All four findings come from one lab; there is no independent replication or evidence in humans, cells, worms or flies.

  3. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 2Jun 2026: 1Jul 2026: 2Aug 2026: 2Sep 2026: 1Oct 2026: 1Nov 2026: 111 papers in 12 months
Frontiers in Aging

Longevity interventions share chemical patterns in male mice

Chemical profiles across seven tissues distinguished controls from male mice given one of five lifespan-extending interventions from 4 to 12 months of age.Chemical profiles across seven tissues distinguished controls from male mice given one of five lifespan-extending interventions from 4 to 12 months of age.

Mouse studyInterventions
bioRxiv

Three drugs may preserve spongy bone in aging female mice

In 22-month-old females, the share of spongy tissue occupied by bone was 1.08 percentage points higher with rapamycin and 1.51 with 17α-estradiol than controls.In 22-month-old females, the share of spongy tissue occupied by bone was 1.08 percentage points higher with rapamycin and 1.51 with 17α-estradiol than controls.

Preprint: mouse studyBones and joints

See all 100 papers on 17-alpha-estradiol